Article

Antibiotic Resistance Now Deemed a "Public Health Crisis"

The above mentioned headline is from an April 30, 2003 article from Reuters Health. On that same date panelists belonging to the Infectious Diseases Society of America (IDSA), the Society for Healthcare Epidemiology of America, along with the Society of Infectious Diseases Pharmacists warned that the medical community is losing the fight against antibiotic-resistant "superbugs" and few new drugs are in development to counter this growing threat. The content states how the panel needed "immediate national action" to limit the threat through judicious usage of antibiotics and better infection-control practices.

Dr. Martin Blaser, chairman of the department of medicine at New York University School of Medicine and a representative of IDSA, told Reuters Health, "Every time you prescribe an antibiotic, you may be affecting not only that patient, but all living and all future living organisms." He continued to state, "Antibiotic resistance is a function of antibiotic use, and we're currently using a great deal of antibiotics. And because there are relatively few antibiotics in the pipeline, once we reach a specific level of resistance, we'll haven't any reinforcements."

Dr. Neil Fishman, director of the department of healthcare epidemiology and infection control and director of the antimicrobial management program at the University of Pennsylvania in Philadelphia, told conference attendees, "We once thought of resistance as predominantly a challenge in hospitals. But it is becoming increasingly more common in the community. We also thought the organisms involved were different, however, all the divisions are blurring."

The purpose about super infections moving outside hospitals was made in an Oct. 23, 2002 Medscape article titled, "Antibiotic-Resistant Staph Moves Outside Hospital". In this posting researchers reporting at an American Academy of Pediatrics meeting stated that doctors need to be alert for an antibiotic-resistant form of a common staph infection that is quickly spreading in some communities. Sheldon Kaplan, MD, professor and vice chair for clinical affairs in the department of pediatrics at Baylor College of Medicine and chief of infectious diseases at Texas Children's Hospital noted that 70% of the community-acquired staph infections treated over the past year at the Texas Children's Hospital in Houston were resistant to a class of antibiotics that were once the first-line treatment. He said, "Five years ago, we didn't see it, now you assume the organism is resistant."

Back to Articles List

image description

QUICKFACTS